Latest Articles

Publication Date
Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence - The ASCO Post

Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence The ASCO Post

Published: March 5, 2026, 4:20 p.m.
Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence - Contemporary OB/GYN

Vaginal estrogen therapy not associated with increased risk of endometrial cancer recurrence Contemporary OB/GYN

Published: March 5, 2026, 12:23 a.m.
Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer - Medical Xpress

Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer Medical Xpress

Published: March 4, 2026, 11:40 p.m.
Is Vaginal Estrogen Safe After Endometrial Cancer? - Medscape

Is Vaginal Estrogen Safe After Endometrial Cancer? Medscape

Published: March 4, 2026, 5:49 p.m.
Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds - News-Medical

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds News-Medical

Published: March 4, 2026, 2:18 p.m.
Vaginal Estrogen Safe for Endometrial Cancer Survivors - Mirage News

Vaginal Estrogen Safe for Endometrial Cancer Survivors Mirage News

Published: March 4, 2026, 5:04 a.m.
Endometriomas are heterogeneous for functional FSH receptor expression and steroidogenic function.

We investigated whether ovarian endometriomas uniformly express functional FSH receptors (FSHR) and respond to FSH by activating transcriptional programs that drive aromatase and steroid hormone production. Endometrioma cyst capsules were …

Published: Feb. 27, 2026, midnight
Systems-level actions of luteolin in female reproductive disorders: from molecular mechanisms to clinical translation.

Female reproductive disorders represent a major global health challenge. Despite their clinical heterogeneity, these conditions share core pathological mechanisms including oxidative stress, chronic inflammation, hormonal imbalance, metabolic dysfunction, extracellular matrix …

Published: Feb. 25, 2026, midnight
Digital patient decision aids for endometriosis management: a scoping review protocol.

Endometriosis is a chronic, oestrogen-dependent condition with a wide range of symptoms and comorbidities that significantly affect physical, emotional and psychological well-being, as well as quality of life. Women with …

Published: Feb. 24, 2026, midnight
The role of gut microbiota in modulating estrogen in the inflammatory milieu of endometriosis: A molecular and pathophysiological perspective.

Endometriosis is a prevalent estrogen-dependent chronic inflammatory condition that affects millions of women of reproductive age worldwide. It is characterized by the growth of endometrial tissue outside the uterine cavity, …

Published: Feb. 24, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!